SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

79 hedge funds and large institutions have $464M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$941K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$27.9M
2 +$5.4M
3 +$3.67M
4
Two Sigma Investments
Two Sigma Investments
New York
+$2.63M
5
State Street
State Street
Massachusetts
+$2.05M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.63M
27
$1.59M
28
$1.01M
29
$982K
30
$886K
31
$886K
32
$752K
33
$719K
34
$670K
35
$667K
36
$664K
37
$621K
38
$598K
39
$585K
40
$570K
41
$524K
42
$522K
43
$431K
44
$422K
45
$417K
46
$377K
47
$271K
48
$266K
49
$261K
50
$252K